Centessa Pharmaceuticals plc ADR’s filing revealed that its Chief Executive Officer SAHA SAURABH unloaded Company’s shares for reported $1.62 million on Dec 06 ’24. In the deal valued at $18.46 per share,87,496 shares were sold. As a result of this transaction, SAHA SAURABH now holds 575,661 shares worth roughly $10.75 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SAHA SAURABH bought 87,496 shares, generating $1,615,255 in total proceeds.
Before that, SAHA SAURABH sold 299 shares. Centessa Pharmaceuticals plc ADR shares valued at $5,451 were divested by the Chief Executive Officer at a price of $18.23 per share. As a result of the transaction, SAHA SAURABH now holds 575,661 shares, worth roughly $10.75 million.
Morgan Stanley upgraded its Centessa Pharmaceuticals plc ADR [CNTA] rating to an Overweight from a an Equal-weight in a research note published on September 20, 2024; the price target was increased to $26 from $11. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Oppenheimer began covering CNTA with “an Outperform” recommendation on July 18, 2024. Jefferies revised its rating on November 15, 2023. It rated CNTA as “a Buy” which previously was an “a Hold”.
Price Performance Review of CNTA
On Friday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 6.75% to $18.67. Over the last five days, the stock has gained 4.24%. Centessa Pharmaceuticals plc ADR shares have risen nearly 134.55% since the year began. Nevertheless, the stocks have risen 178.66% over the past one year. While a 52-week high of $18.74 was reached on 12/06/24, a 52-week low of $6.15 was recorded on 01/11/24. SMA at 50 days reached $16.38, while 200 days put it at $12.22.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 17.96, which if violated will result in even more drops to 17.24. On the upside, there is a resistance level at 19.08. A further resistance level may holdings at 19.48. The Relative Strength Index (RSI) on the 14-day chart is 63.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 2.65%. Stochastics %K at 79.00% indicates the stock is a holding.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2024-11-15, growing by 0.43 million shares to a total of 2.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 2.01 million shares. There was a rise of 17.49%, which implies that there is a positive sentiment for the stock.
